Drug Facts
Composition & Profile
Identifiers & Packaging
HOW SUPPLIED Clotrimazole topical solution USP, 1% is supplied in 30 mL plastic bottles (NDC 52817-800-30); boxes of one. Store between 2° to 30°C (36° to 86°F).; PRINCIPAL DISPLAY PANEL - 30 mL Bottle Carton NDC 52817-800-30 Clotrimazole Topical Solution USP, 1% FOR EXTERNAL USE ONLY. NOT FOR OPHTHALMIC USE. Keep this and all medications out of the reach of children. Rx only 30 mL Carton label
- HOW SUPPLIED Clotrimazole topical solution USP, 1% is supplied in 30 mL plastic bottles (NDC 52817-800-30); boxes of one. Store between 2° to 30°C (36° to 86°F).
- PRINCIPAL DISPLAY PANEL - 30 mL Bottle Carton NDC 52817-800-30 Clotrimazole Topical Solution USP, 1% FOR EXTERNAL USE ONLY. NOT FOR OPHTHALMIC USE. Keep this and all medications out of the reach of children. Rx only 30 mL Carton label
Overview
Clotrimazole topical solution USP, 1% contains 10 mg clotrimazole USP, a synthetic antifungal agent having the chemical name 1-(o-Chloro-α,α-diphenylbenzyl) imidazole with the following strctural formula: MOLECULAR FORMULA C 22 H 17 CIN 2 MOLECULAR WEIGHT 344.85 Clotrimazole is an odorless, white crystalline substance. It is practically insoluble in water, sparingly soluble in ether and very soluble in polyethylene glycol 400, ethanol, and chloroform. Each mL of clotrimazole topical solution USP, 1% contains 10 mg clotrimazole USP in a nonaqueous vehicle of polyethylene glycol 400. clotrimazole-01.jpg
Indications & Usage
Prescription clotrimazole topical solution product is indicated for the topical treatment of candidiasis due to Candida albicans and tinea versicolor due to Malassezia furfur . This formulation is also available as a nonprescription product which is indicated for the topical treatment of the following dermal infections: tinea pedis, tinea cruris, and tinea corporis due to Trichophyton rubrum, Trichophyton mentagrophytes , Epidermophyton fluoccosum , and Microsporum canis .
Dosage & Administration
Gently massage sufficient clotrimazole topical solution USP, 1% into the affected and surrounding skin areas twice a day, in the morning and evening. Clinical improvement, with relief of pruritus, usually occurs within the first week of treatment with clotrimazole topical solution USP, 1%. If the patient shows no clinical improvement after 4 weeks of treatment with clotrimazole topical solution USP, 1%, the diagnosis should be reviewed.
Warnings & Precautions
WARNINGS Clotrimazole topical solution is not for ophthalmic use.
Contraindications
Topical antifungal agents are contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation.
Adverse Reactions
The following adverse reactions have been reported in connection with the use of clotrimazole: erythema, stinging, blistering, peeling, edema, pruritius, urticaria, burning, and general irritation of the skin.
Drug Interactions
Synergism or antagonism between clotrimazole and nystatin, or amphotericin B, or flucytosine against strains of C. albicans has not been reported.
Storage & Handling
Store between 2° to 30°C (36° to 86°F).
Similar Drugs
Related medications based on brand, generic name, substance, active ingredients.